Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FCDDX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,420
Award facts
- Contract value 100% obligated
- $15,420.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Jardiance 25 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $15,420.17. This delivery order, issued without a set-aside designation through open competition, represents a single-line item procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The ultimate completion date is set for September 11, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA Pharmaceutical Prime Vendor Global Program, the company supplies a comprehensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Jardiance delivery order exemplifies the company's role in supporting military medical supply chains with essential medications, in this case a diabetes management pharmaceutical, demonstrating its capability to fulfill federal procurement requirements across diverse therapeutic domains through competitively awarded contracts with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DB25FCDDX?
SPE2DB25FCDDX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FCDDX worth?
The government has obligated $15,420 on SPE2DB25FCDDX.
Is contract SPE2DB25FCDDX an order under another contract?
Yes. SPE2DB25FCDDX is a delivery order under SPE2DB24D1007, an indefinite delivery contract.
Was contract SPE2DB25FCDDX competed?
The extent of competition for SPE2DB25FCDDX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award